Express Scripts (ESRX) Reports In-Line Q1 EPS, Raises FY EPS Guidance

Express Scripts (NASDAQ: ESRX) reported Q1 EPS of $1.22, in-line with the analyst estimate of $1.22. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.2 billion.

GUIDANCE:

Express Scripts sees Q2 2016 EPS of $1.55-$1.59, versus the consensus of $1.57.

Express Scripts sees FY2016 EPS of $6.31-$6.43, versus prior guidance of $6.10-$6.28 and the consensus of $6.17.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c